Ambeed.cn

首页 / 抑制剂/激动剂 / / / BL-918

BL-918 {[allProObj[0].p_purity_real_show]}

货号:A1250770

BL-918是一种口服活性的 UNC-51 类激酶 1 (ULK1) 激活剂,EC50 为 24.14 nM,能诱导保护性自噬,用于治疗帕金森病。

BL-918 化学结构 CAS号:2101517-69-3
BL-918 化学结构
CAS号:2101517-69-3
BL-918 3D分子结构
CAS号:2101517-69-3
BL-918 化学结构 CAS号:2101517-69-3
BL-918 3D分子结构 CAS号:2101517-69-3
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

BL-918 纯度/质量文件 产品仅供科研

货号:A1250770 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Neuron, 2025. Ambeed. [ A1440350 ]
Nature Communications, 2025, 16, 996. Ambeed. [ A111960 , A505336 ]
JACS, 2025. Ambeed. [ A349578 , A2270125 ]
PLoS Biol., 2025, 23(2): e3002961. Ambeed. [ A181909 ]
Redox Rep., 2025, 30(1): 2454887. Ambeed. [ A1155014 ]
更多 >
产品名称 Autophagy 其他靶点 纯度
SBI-0206965 +++

ULK1, IC50: 108 nM

ULK2, IC50: 711 nM

97%
Hydroxychloroquine sulfate 99%
Valproic acid sodium HDAC 97%
PFK-015 ++

PFKFB3, IC50: 207 nM

99%+
MRT68921 hydrochloride ++++

ULK1, IC50: 2.9 nM

ULK2, IC50: 1.1 nM

99%+
ROC-325 99%+
Autophinib +++

Autophagy, IC50: 40 nM

99%
Lys05 99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

BL-918 生物活性

描述 UNC-51-like kinase 1 (ULK1), the yeast Atg1 ortholog, is the sole serine-threonine kinase and initiating enzyme in autophagy, which may be regarded as a target in Parkinson's disease (PD). BL-918 is a novel ULK1 activator that potently activates ULK1 with an EC50 of 24.14 nM. BL-918 could enhance the phosphorylation level of mAtg13 in HEK-293T cells transfected with ULK1WT, indicating BL-918 activates ULK1 in vitro. BL-918 (5 μM; 24 h) treatment induced some vacuolar elements that were most likely to be of autophagic origin in SH-SY5Y cells. BL-918 (5 μM for 0, 6, 12, 24, and 36 h) time-dependently elevated the expression levels of LC3-II (a key marker of autophagy), Beclin-1, and its phosphorylation status, whereas the level of the selective autophagy substrate SQSTM1/p62 was reduced after treatment with BL-918. Moreover, LC3 and SQSTM1/p62 were significantly accumulated after 24 h cotreatment with BL-918 (5 μM) and Bafilomycin A1 (10 nM), indicating that BL-918 treatment enhances the autophagic flux. Interestingly, BL-918 (5 μM; 24 h) treatment induced autophagosome accumulation in PC-12 cells, which was indicated by increased expression levels of LC3-II and SQSTM1/p62, as well as the aggregated LC3 puncta in PC-12 cells. Meanwhile, BL-918 (5 μM; 24 h) treatment led to the increase of the GFP-LC3 puncta in SH-SY5Y cells, which was markedly decreased under the treatment of 3-MA (2 mM; 24 h; a class III PI3K autophagy inhibitor, could block BL-918-induced autophagy). MPP+ (1 mM) was added to SH-SY5Y cells with 0.5, 5, and 50 μM BL-918 with or without 2 mM 3-MA. BL-918 could partially reverse MPP+-induced cell death, which was determined by enhancing cell viability. In a MPTP-induced PD mouse model, the time to turn and time to finish for the MPTP-treated mice were longer than that for the vehicle-treated mice, which are significantly restored in the median- (40 mg/kg) and high-dose (80 mg/kg) BL-918-treated mice demonstrating that BL-918 has a good therapeutic potential on PD models in vivo[1].
作用机制 Some key amino acid residues (Arg18, Lys50, Asn86, and Tyr89) were found to be crucial to the binding pocket between ULK1 and BL-918 by site-directed mutagenesis[1].

BL-918 参考文献

[1]Small-Molecule Activator of UNC-51-Like Kinase 1 (ULK1) That Induces Cytoprotective Autophagy for Parkinson's Disease Treatment

BL-918 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.87mL

0.37mL

0.19mL

9.37mL

1.87mL

0.94mL

18.75mL

3.75mL

1.87mL

BL-918 技术信息

CAS号2101517-69-3
分子式C23H15F8N3OS
分子量 533.437
别名
运输蓝冰
存储条件

In solvent -20°C:3-6个月-80°C:12个月

Pure form Sealed in dry,2-8°C

溶解方案

DMSO: 250 mg/mL(468.66 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案一
动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。